_id
690da9adccc777a4e85d0867
Ticker
ADGM
Name
Adagio Medical Holdings, Inc Common Stock
Exchange
NASDAQ
Address
26051 Merit Circle, Laguna Hills, CA, United States, 92653
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://adagiomedical.com
Description
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Last Close
0.871
Volume
24024
Current Price
0.88
Change
-0.0199
Last Updated
2026-01-21T21:23:50.476Z
Image
data:image/webp;base64,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
Ipo Date
2024-08-01T00:00:00.000Z
Market Cap
18447462
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
31000
Gross Profit
-31000
Operating Expenses
5690000
Operating Income
-5721000
Interest Expense
749000
Pretax Income
-10118000
Net Income
-10118000
Eps
-0.6578004253793421
Dividends Per Share
-
Shares Outstanding
21179637
Income Tax Expense
-
EBITDA
-9178000
Operating Margin
-
Total Other Income Expense Net
-4397000
Cash
4673000
Short Term Investments
-
Receivables
0
Inventories
1548000
Total Current Assets
8143000
Property Plant Equipment
2461000
Total Assets
31546000
Payables
1024000
Short Term Debt
180000
Long Term Debt
21191000
Total Liabilities
32858000
Equity
-1312000
Bs_currency_symbol
USD
Depreciation
191000
Change In Working Capital
2535000
Cash From Operations
-3009000
Capital Expenditures
520000
Cash From Investing
-520000
Cash From Financing
0
Net Change In Cash
-3526999
Cf_currency_symbol
USD
PE
-
PB
-10.316903353658537
ROE
771.189024390244
ROA
-32.07379699486464
FCF
-3529000
Fcf Percent
-
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
1.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
3
Net Net Investing Score
1
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
31000
Quarters > 0 > income Statement > gross Profit
-31000
Quarters > 0 > income Statement > operating Expenses
5690000
Quarters > 0 > income Statement > operating Income
-5721000
Quarters > 0 > income Statement > interest Expense
749000
Quarters > 0 > income Statement > pretax Income
-10118000
Quarters > 0 > income Statement > net Income
-10118000
Quarters > 0 > income Statement > eps
-0.6578004253793421
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
15381565
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-9178000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-4397000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
4673000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
0
Quarters > 0 > balance Sheet > inventories
1548000
Quarters > 0 > balance Sheet > total Current Assets
8143000
Quarters > 0 > balance Sheet > property Plant Equipment
2461000
Quarters > 0 > balance Sheet > total Assets
31546000
Quarters > 0 > balance Sheet > payables
1024000
Quarters > 0 > balance Sheet > short Term Debt
180000
Quarters > 0 > balance Sheet > long Term Debt
21191000
Quarters > 0 > balance Sheet > total Liabilities
32858000
Quarters > 0 > balance Sheet > equity
-1312000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-10118000
Quarters > 0 > cash Flow > depreciation
191000
Quarters > 0 > cash Flow > change In Working Capital
2535000
Quarters > 0 > cash Flow > cash From Operations
-3009000
Quarters > 0 > cash Flow > capital Expenditures
520000
Quarters > 0 > cash Flow > cash From Investing
-520000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-3526999
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.6578004253793421
Quarters > 0 > ratios > PB
-10.316903353658537
Quarters > 0 > ratios > ROE
771.189024390244
Quarters > 0 > ratios > ROA
-32.07379699486464
Quarters > 0 > ratios > FCF
-3529000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
342000
Quarters > 1 > income Statement > gross Profit
-342000
Quarters > 1 > income Statement > operating Expenses
4375000
Quarters > 1 > income Statement > operating Income
-4717000
Quarters > 1 > income Statement > interest Expense
720000
Quarters > 1 > income Statement > pretax Income
-3947000
Quarters > 1 > income Statement > net Income
-3947000
Quarters > 1 > income Statement > eps
-0.25660587853056566
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
15381565
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-4446000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
770000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
8200000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
0
Quarters > 1 > balance Sheet > inventories
1841000
Quarters > 1 > balance Sheet > total Current Assets
12227000
Quarters > 1 > balance Sheet > property Plant Equipment
2704000
Quarters > 1 > balance Sheet > total Assets
35876000
Quarters > 1 > balance Sheet > payables
1315000
Quarters > 1 > balance Sheet > short Term Debt
205000
Quarters > 1 > balance Sheet > long Term Debt
16945000
Quarters > 1 > balance Sheet > total Liabilities
27210000
Quarters > 1 > balance Sheet > equity
8666000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-3947000
Quarters > 1 > cash Flow > depreciation
271000
Quarters > 1 > cash Flow > change In Working Capital
72000
Quarters > 1 > cash Flow > cash From Operations
-4656000
Quarters > 1 > cash Flow > capital Expenditures
10000
Quarters > 1 > cash Flow > cash From Investing
-10000
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-4763000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.25660587853056566
Quarters > 1 > ratios > PB
1.5619405954304177
Quarters > 1 > ratios > ROE
-45.54581121624741
Quarters > 1 > ratios > ROA
-11.001783922399376
Quarters > 1 > ratios > FCF
-4666000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
17
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
-143000
Quarters > 2 > income Statement > cost Of Revenue
253000
Quarters > 2 > income Statement > gross Profit
-253000
Quarters > 2 > income Statement > operating Expenses
7144000
Quarters > 2 > income Statement > operating Income
-7397000
Quarters > 2 > income Statement > interest Expense
662000
Quarters > 2 > income Statement > pretax Income
-7713000
Quarters > 2 > income Statement > net Income
-7713000
Quarters > 2 > income Statement > eps
-0.501641537870489
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
15375521
Quarters > 2 > income Statement > income Tax Expense
9124342
Quarters > 2 > income Statement > EBITDA
-7126000
Quarters > 2 > income Statement > operating Margin
5172.727272727273
Quarters > 2 > income Statement > total Other Income Expense Net
-316000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
12963000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1000
Quarters > 2 > balance Sheet > inventories
2310000
Quarters > 2 > balance Sheet > total Current Assets
17373000
Quarters > 2 > balance Sheet > property Plant Equipment
3018000
Quarters > 2 > balance Sheet > total Assets
41338000
Quarters > 2 > balance Sheet > payables
2647000
Quarters > 2 > balance Sheet > short Term Debt
263000
Quarters > 2 > balance Sheet > long Term Debt
17652000
Quarters > 2 > balance Sheet > total Liabilities
28939000
Quarters > 2 > balance Sheet > equity
12399000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-7713000
Quarters > 2 > cash Flow > depreciation
271000
Quarters > 2 > cash Flow > change In Working Capital
241000
Quarters > 2 > cash Flow > cash From Operations
-7211000
Quarters > 2 > cash Flow > capital Expenditures
335000
Quarters > 2 > cash Flow > cash From Investing
-335000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-7623000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.501641537870489
Quarters > 2 > ratios > PB
1.0912540108073232
Quarters > 2 > ratios > ROE
-62.20662956690056
Quarters > 2 > ratios > ROA
-18.658377279984517
Quarters > 2 > ratios > FCF
-7546000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
52.76923076923077
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
185000
Quarters > 3 > income Statement > cost Of Revenue
571000
Quarters > 3 > income Statement > gross Profit
-386000
Quarters > 3 > income Statement > operating Expenses
10245000
Quarters > 3 > income Statement > operating Income
-10631000
Quarters > 3 > income Statement > interest Expense
739000
Quarters > 3 > income Statement > pretax Income
-4629000
Quarters > 3 > income Statement > net Income
-4629000
Quarters > 3 > income Statement > eps
-0.3184696723855903
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
14535136
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-3633999
Quarters > 3 > income Statement > operating Margin
-5746.486486486487
Quarters > 3 > income Statement > total Other Income Expense Net
6002000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
28260000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
90000
Quarters > 3 > balance Sheet > inventories
4139000
Quarters > 3 > balance Sheet > total Current Assets
35030000
Quarters > 3 > balance Sheet > property Plant Equipment
1798000
Quarters > 3 > balance Sheet > total Assets
107196000
Quarters > 3 > balance Sheet > payables
4419000
Quarters > 3 > balance Sheet > short Term Debt
142000
Quarters > 3 > balance Sheet > long Term Debt
13750000
Quarters > 3 > balance Sheet > total Liabilities
30635000
Quarters > 3 > balance Sheet > equity
76561000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-4629000
Quarters > 3 > cash Flow > depreciation
256000
Quarters > 3 > cash Flow > change In Working Capital
1667000
Quarters > 3 > cash Flow > cash From Operations
-8664000
Quarters > 3 > cash Flow > capital Expenditures
609000
Quarters > 3 > cash Flow > cash From Investing
-609000
Quarters > 3 > cash Flow > cash From Financing
990000
Quarters > 3 > cash Flow > net Change In Cash
26215000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.3184696723855903
Quarters > 3 > ratios > PB
0.16706834654719765
Quarters > 3 > ratios > ROE
-6.046159271691853
Quarters > 3 > ratios > ROA
-4.318258143960596
Quarters > 3 > ratios > FCF
-9273000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-50.12432432432433
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
269000
Annuals > 0 > income Statement > cost Of Revenue
1937000
Annuals > 0 > income Statement > gross Profit
-1668000
Annuals > 0 > income Statement > operating Expenses
60812000
Annuals > 0 > income Statement > operating Income
-62480000
Annuals > 0 > income Statement > interest Expense
1102000
Annuals > 0 > income Statement > pretax Income
-53763000
Annuals > 0 > income Statement > net Income
-53763000
Annuals > 0 > income Statement > eps
-3.537450935082449
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
15198232
Annuals > 0 > income Statement > income Tax Expense
-53763000
Annuals > 0 > income Statement > EBITDA
-62480000
Annuals > 0 > income Statement > operating Margin
-23226.765799256507
Annuals > 0 > income Statement > total Other Income Expense Net
8717000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
20586000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
35000
Annuals > 0 > balance Sheet > inventories
2566000
Annuals > 0 > balance Sheet > total Current Assets
25349000
Annuals > 0 > balance Sheet > property Plant Equipment
2149000
Annuals > 0 > balance Sheet > total Assets
48448000
Annuals > 0 > balance Sheet > payables
2840000
Annuals > 0 > balance Sheet > short Term Debt
143000
Annuals > 0 > balance Sheet > long Term Debt
16076000
Annuals > 0 > balance Sheet > total Liabilities
28536000
Annuals > 0 > balance Sheet > equity
19912000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-75041000
Annuals > 0 > cash Flow > depreciation
1386000
Annuals > 0 > cash Flow > change In Working Capital
5787000
Annuals > 0 > cash Flow > cash From Operations
-29459000
Annuals > 0 > cash Flow > capital Expenditures
1648000
Annuals > 0 > cash Flow > cash From Investing
-1648000
Annuals > 0 > cash Flow > cash From Financing
15633000
Annuals > 0 > cash Flow > net Change In Cash
20565809
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-3.537450935082449
Annuals > 0 > ratios > PB
0.6716775893933307
Annuals > 0 > ratios > ROE
-270.0030132583367
Annuals > 0 > ratios > ROA
-110.9705250990753
Annuals > 0 > ratios > FCF
-31107000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-115.63940520446097
Annuals > 0 > health Score
23
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
300000
Annuals > 1 > income Statement > cost Of Revenue
1306000
Annuals > 1 > income Statement > gross Profit
-1006000
Annuals > 1 > income Statement > operating Expenses
26936000
Annuals > 1 > income Statement > operating Income
-27942000
Annuals > 1 > income Statement > interest Expense
1659000
Annuals > 1 > income Statement > pretax Income
-38146000
Annuals > 1 > income Statement > net Income
-38146000
Annuals > 1 > income Statement > eps
-4.855848289174638
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
7855682
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-27410000
Annuals > 1 > income Statement > operating Margin
-9314
Annuals > 1 > income Statement > total Other Income Expense Net
-10204000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1383000
Annuals > 1 > balance Sheet > short Term Investments
1362809
Annuals > 1 > balance Sheet > receivables
71000
Annuals > 1 > balance Sheet > inventories
3322000
Annuals > 1 > balance Sheet > total Current Assets
5185000
Annuals > 1 > balance Sheet > property Plant Equipment
1617000
Annuals > 1 > balance Sheet > total Assets
6825000
Annuals > 1 > balance Sheet > payables
3830000
Annuals > 1 > balance Sheet > short Term Debt
38204000
Annuals > 1 > balance Sheet > long Term Debt
143000
Annuals > 1 > balance Sheet > total Liabilities
138848000
Annuals > 1 > balance Sheet > equity
-132023000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-36590000
Annuals > 1 > cash Flow > depreciation
548000
Annuals > 1 > cash Flow > change In Working Capital
-32000
Annuals > 1 > cash Flow > cash From Operations
-25652000
Annuals > 1 > cash Flow > capital Expenditures
333000
Annuals > 1 > cash Flow > cash From Investing
-340000
Annuals > 1 > cash Flow > cash From Financing
21875000
Annuals > 1 > cash Flow > net Change In Cash
-4164000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-4.855848289174638
Annuals > 1 > ratios > PB
-0.05236208963589677
Annuals > 1 > ratios > ROE
28.893450383645273
Annuals > 1 > ratios > ROA
-558.9157509157509
Annuals > 1 > ratios > FCF
-25985000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-86.61666666666666
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
189000
Annuals > 2 > income Statement > cost Of Revenue
875000
Annuals > 2 > income Statement > gross Profit
-686000
Annuals > 2 > income Statement > operating Expenses
23227000
Annuals > 2 > income Statement > operating Income
-23913000
Annuals > 2 > income Statement > interest Expense
137000
Annuals > 2 > income Statement > pretax Income
-23673000
Annuals > 2 > income Statement > net Income
-23673000
Annuals > 2 > income Statement > eps
-1.2338362911422094
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
19186500
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-23041000
Annuals > 2 > income Statement > operating Margin
-12652.380952380952
Annuals > 2 > income Statement > total Other Income Expense Net
240000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
5547000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-6585551
Annuals > 2 > balance Sheet > inventories
367000
Annuals > 2 > balance Sheet > total Current Assets
6732000
Annuals > 2 > balance Sheet > property Plant Equipment
1939000
Annuals > 2 > balance Sheet > total Assets
8697000
Annuals > 2 > balance Sheet > payables
1011000
Annuals > 2 > balance Sheet > short Term Debt
9663000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
104574000
Annuals > 2 > balance Sheet > equity
-95877000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-23673000
Annuals > 2 > cash Flow > depreciation
495000
Annuals > 2 > cash Flow > change In Working Capital
330000
Annuals > 2 > cash Flow > cash From Operations
-22412000
Annuals > 2 > cash Flow > capital Expenditures
492000
Annuals > 2 > cash Flow > cash From Investing
-500000
Annuals > 2 > cash Flow > cash From Financing
9525000
Annuals > 2 > cash Flow > net Change In Cash
5045759
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.2338362911422094
Annuals > 2 > ratios > PB
-0.17610188053443476
Annuals > 2 > ratios > ROE
24.691010357019934
Annuals > 2 > ratios > ROA
-272.19730941704034
Annuals > 2 > ratios > FCF
-22904000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-121.18518518518519
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
270000
Annuals > 3 > income Statement > cost Of Revenue
1158000
Annuals > 3 > income Statement > gross Profit
-888000
Annuals > 3 > income Statement > operating Expenses
19757000
Annuals > 3 > income Statement > operating Income
-20645000
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-19938000
Annuals > 3 > income Statement > net Income
-19938000
Annuals > 3 > income Statement > eps
-1.0391681651160973
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
19186500
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-19602000
Annuals > 3 > income Statement > operating Margin
-7646.2962962962965
Annuals > 3 > income Statement > total Other Income Expense Net
707000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
18853000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
33000
Annuals > 3 > balance Sheet > inventories
334000
Annuals > 3 > balance Sheet > total Current Assets
19724000
Annuals > 3 > balance Sheet > property Plant Equipment
1698000
Annuals > 3 > balance Sheet > total Assets
21444000
Annuals > 3 > balance Sheet > payables
578000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
94062000
Annuals > 3 > balance Sheet > equity
-72618000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-19938000
Annuals > 3 > cash Flow > depreciation
336000
Annuals > 3 > cash Flow > change In Working Capital
579000
Annuals > 3 > cash Flow > cash From Operations
-19307000
Annuals > 3 > cash Flow > capital Expenditures
1272000
Annuals > 3 > cash Flow > cash From Investing
-1272000
Annuals > 3 > cash Flow > cash From Financing
130000
Annuals > 3 > cash Flow > net Change In Cash
-20380000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.0391681651160973
Annuals > 3 > ratios > PB
-0.23250599025035115
Annuals > 3 > ratios > ROE
27.45600264397257
Annuals > 3 > ratios > ROA
-92.9770565193061
Annuals > 3 > ratios > FCF
-20579000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-76.21851851851852
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.6578004253793421
Valuation > metrics > PB
-10.316903353658537
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
771.189024390244
Profitability > metrics > ROA
-124.25396045683411
Profitability > metrics > Net Margin
-
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Debt Equity
-
Risk > metrics > Interest Coverage
-7.638184245660881
Risk > final Score
-1
Risk > verdict
High
Liquidity > metrics > Current Ratio
-
Liquidity > metrics > Quick Ratio
-
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
30
Prev Profitabilities > 2
0
Prev Risks > 0
-20
Prev Risks > 1
-27
Prev Risks > 2
2
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-21T21:23:51.179Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-06-30
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.3494
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-03-31
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.5016
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-12-31
Earnings History > 2 > report Date
2024-12-31
Earnings History > 2 > date
2024-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-3.7747
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-09-30
Earnings History > 3 > report Date
2024-09-30
Earnings History > 3 > date
2024-09-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.3185
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-06-30
Earnings History > 4 > report Date
2024-06-30
Earnings History > 4 > date
2024-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-6.4408
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-03-31
Earnings History > 5 > report Date
2024-03-31
Earnings History > 5 > date
2024-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-10.2807
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2023-12-31
Earnings History > 6 > report Date
2023-12-31
Earnings History > 6 > date
2023-12-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.28
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-09-30
Earnings History > 7 > report Date
2023-09-30
Earnings History > 7 > date
2023-09-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0613
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-06-30
Earnings History > 8 > report Date
2023-06-30
Earnings History > 8 > date
2023-06-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0.0514
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-03-31
Earnings History > 9 > report Date
2023-03-31
Earnings History > 9 > date
2023-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.0106
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2022-12-31
Earnings History > 10 > report Date
2022-12-31
Earnings History > 10 > date
2022-12-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0889
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-09-30
Earnings History > 11 > report Date
2022-09-30
Earnings History > 11 > date
2022-09-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.1658
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-06-30
Earnings History > 12 > report Date
2022-06-30
Earnings History > 12 > date
2022-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.0102
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-03-31
Earnings History > 13 > report Date
2022-03-31
Earnings History > 13 > date
2022-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.011
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2021-12-31
Earnings History > 14 > report Date
2021-12-31
Earnings History > 14 > date
2021-12-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0571
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-09-30
Earnings History > 15 > report Date
2021-09-30
Earnings History > 15 > date
2021-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.2655
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-06-30
Earnings History > 16 > report Date
2021-06-30
Earnings History > 16 > date
2021-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.0085
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-03-31
Earnings History > 17 > report Date
2021-03-31
Earnings History > 17 > date
2021-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.011
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABuyout Rumor: Why is VCXB WS stock going up - Market Weekly Review & Consistent Profit Alerts baoquankhu1.vn
Read more →Financial Review: SiBone (NASDAQ:SIBN) vs. Adagio Medical (NASDAQ:ADGM) Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Adagio Medical Holdings, Inc Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.3494
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.